⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25422828 | 0.83 | HTT (0.37) | — | |
| SCHEMBL7927506 | 0.79 | HTT (0.50) | — | |
| SCHEMBL6660567 | 0.77 | MAPK1 (0.39) | — | |
| SCHEMBL308851 | 0.77 | HTT (0.59) | — | |
| SCHEMBL1143909 | 0.77 | HTT (0.59) | — | |
| SCHEMBL619831 | 0.75 | HTT (0.46) | — | |
| SCHEMBL31445480 | 0.75 | HTT (0.32) | — | |
| SCHEMBL11148198 | 0.75 | TSHR (0.43) | — | |
| SCHEMBL25076174 | 0.75 | HTT (0.32) | — | |
| SCHEMBL308852 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 330 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4721152-A2 | ORGANIC THIN FILM COATINGS FOR BATTERY MATERIALS | Coreshell Technologies, Inc. (US) | 2026-04-08 | — | — | EP | claimed |
| WO-2025038699-A9 | PROCESSES OF PREPARING PI3K INHIBITORS | SCORPION THERAPEUTICS, INC. (US) | 2025-03-20 | — | — | WO | claimed |
| WO-2025038699-A1 | PROCESSES OF PREPARING PI3K INHIBITORS | SCORPION THERAPEUTICS, INC. (US) | 2025-02-20 | — | — | WO | claimed |
| WO-2024249841-A2 | ORGANIC THIN FILM COATINGS FOR BATTERY MATERIALS | CORESHELL TECHNOLOGIES, INC. (US) | 2024-12-05 | — | — | WO | claimed |
| WO-2018127936-A1 | NOVEL ECONOMIC METAL FREE PROCESS FOR APIXABAN | HIKAL LIMITED (IN) | 2018-07-12 | — | — | WO | claimed |
| EP-3110795-A1 | NOVEL ECONOMIC PROCESS FOR VILDAGLIPTIN | Hikal Limited (IN) | 2017-01-04 | — | — | EP | claimed |
| CN-106029635-A | Novel economic process for vildagliptin | 海蔻有限公司 | 2016-10-12 | — | — | CN | claimed |
| WO-2015128718-A1 | NOVEL ECONOMIC PROCESS FOR VILDAGLIPTIN | HIKAL LIMITED (IN) | 2015-09-03 | — | — | WO | claimed |
| EP-0630382-B1 | LACTAM DIPEPTIDES HAVING HLE INHIBITING ACTIVITY | ZENECA LTD (GB) | 1997-02-26 | — | — | EP | claimed |
| WO-1993021212-A1 | LACTAM DIPEPTIDES HAVING HLE INHIBITING ACTIVITY | ZENECA LIMITED (GB) | 1993-10-28 | — | — | WO | claimed |
| EP-4747258-A2 | COMPOUNDS, COMPOSITIONS, AND METHODS | Tenvie Therapeutics, Inc. (US) | 2026-05-27 | — | — | EP | disclosed |
| EP-4721152-A2 | ORGANIC THIN FILM COATINGS FOR BATTERY MATERIALS | Coreshell Technologies, Inc. (US) | 2026-04-08 | — | — | EP | disclosed |
| EP-4714446-A2 | PHARMACEUTICAL COMPOUNDS | Nxera Pharma UK Limited (GB) | 2026-03-25 | — | — | EP | disclosed |
| US-12552767-B2 | 3-heteroaryl pyrrolidine and piperidine orexin receptor agonists | MERCK SHARP & DOHME LLC (US) | 2026-02-17 | — | — | US | disclosed |
| US-12552770-B2 | Compounds for treating respiratory disease | TMEM16A LIMITED (GB) | 2026-02-17 | — | — | US | disclosed |
| US-4411838-A | PROMOTER ADDITIVES FOR PROPELLANTS AND EXPLOSIVES | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 1983-10-25 | — | — | US | disclosed |
| US-4332744-A | ENERGETIC ADDITIVES TO PROPELLANTS AND EXPLOSIVES | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 1982-06-01 | — | — | US | disclosed |
| US-4201783-A | Antidepressant substituted hexahydro benzopyrano [3,2-c] pyridines | LIPHA LYONNAISE INDUSTRIELLE PHARMACEUTIQUE (FR) | 1980-05-06 | — | — | US | disclosed |
| US-4022609-A | MITICIDES | PPG INDUSTRIES, INC. (US) | 1977-05-10 | — | — | US | disclosed |
| US-3998816-A | 7-[5-N-(n-Butoxyethoxy carbonyl and 2-chloroethoxy carbonyl)-amino] cephalosporins C | MEIJI SEIKA KAISHA, LTD. (JA) | 1976-12-21 | — | — | US | disclosed |